Target intelligence / Profile preview

Tyrosine-protein phosphatase non-receptor type 4 (PTPN4)

Target
PTPN4
Molecular classification
Enzyme (specifically, protein tyrosine phosphatase), Non-receptor tyrosine phosphatase, Member of the classical phosphotyrosine-specific PTP subfamily
01

Overview

Tyrosine-protein phosphatase non-receptor type 4 (PTPN4) is a member of the protein tyrosine phosphatase family, acting as a signaling molecule regulating cell growth, differentiation, cell cycle, and transformation[1][4]. It has a C-terminal phosphatase domain and an N-terminal region related to the band 4.1 superfamily, suggesting links to cytoskeletal association[1][3]. PTPN4 interacts with subunits of glutamate receptors and is believed to modulate synaptic and cytoskeletal signaling through tyrosine dephosphorylation[1]. Genetic and functional studies suggest PTPN4 and related PTPs are essential for normal cellular homeostasis, and their dysregulation is involved in the onset of diseases such as cancer[2][4]. Structural analysis reveals diversity among phosphatases relevant for inhibitor design, but PTPN4-specific drug development is still at a preclinical stage[3].

Other names
PTPN4MEGPTPase-MEG1PTPMEGProtein-tyrosine phosphatase MEG1Megakaryocyte phosphataseMegakaryocyte protein-tyrosine phosphatasePTPMEG1
02

Mechanism of action

Potential mechanisms center on inhibition of enzymatic activity by small molecules (e.g., targeting the active site) Modulation of substrate or secondary binding pockets, as revealed by structural studies[3][2]

03

Biological functions

Signal transduction (regulates downstream signaling, especially of glutamate receptors)Cell growthCell differentiationCell cycle (mitotic cycle) regulationOncogenic transformation
04

Disease associations

Cancer (altered expression or oxidation can contribute to oncogenesis)Possibly relevant for other disorders involving aberrant tyrosine phosphorylation, with potential implication in immune-related and neuropsychiatric diseases (general for PTPs)Other (role in megakaryocyte and neuronal signaling, though direct links to specific diseases for PTPN4 are less characterized in the literature)
05

Safety considerations

General challenges for PTP inhibitors include selectivity (due to conserved active sites), off-target effects, and disruption of essential signaling processes leading to unwanted toxicity[4][2].
06

Interacting drugs

No clinically approved drugs directly target PTPN4 as of the current literature; PTPs are under active investigation for the development of small-molecule inhibitors[2][4].
07

Biomarkers

No established biomarkers for patient selection or efficacy monitoring specific to PTPN4[4]. Identification of altered PTP activity and redox status is being explored in cancer and other disease contexts.

Beyond the preview

Go deeper on Tyrosine-protein phosphatase non-receptor type 4 (PTPN4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyrosine-protein phosphatase non-receptor type 4 (PTPN4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call